/PRNewswire/ Spinal Stabilization Technologies (SST) has announced the start of the LOPAIN2 clinical trial of the PerQdisc™ Nucleus Replacement Device (NRD)..
The Saturday after Thanksgiving is traditionally reserved to celebrate small businesses and encourage shoppers to patron their local hometown stores. This year’s holiday is especially important, as many small businesses
Spinal Stabilization Technologies Ltd Earns CE Mark, FDA Breakthrough Designation For PerQdisc Nucleus Replacement System For Degenerative Disc Disease
USA - English
Share this article
Share this article
KILKENNY, Ireland, May 25, 2021 /PRNewswire/ Spinal Stabilization Technologies, Ltd. (SST), Kilkenny, Ireland announced today that it has earned the CE Mark and the FDA s breakthrough designation for its PerQdisc™ Nucleus Replacement System.
PerQdisc is the only commercially available lumbar nucleus replacement system in the world. The PerQdisc device replaces the nucleus pulposus of the intervertebral disc in the L1 - S1 spinal region in patients with single-level discogenic pain. The patient may have single or multi-level degenerative disc disease (DDD) but the discogenic pain must be limited to a single level.
SST obtiene la marca CE para el sistema PerQdisc europapress.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europapress.es Daily Mail and Mail on Sunday newspapers.